In this study we have explored potential benefits of applying p19Arf/IFNβ gene therapy in association with Dox chemotherapy, both of which elicit ICD, and as postulated here, their interplay could act on different levels of the therapeutic response. Here, IFNB1 is linked to impulse control disorder.